-
EP3299977
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3299977
| EP3299977 - COMPOSITIONS AND METHODS RELATED TO DIAGNOSIS OF PROSTATE CANCER [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 01.09.2023 Database last updated on 04.06.2024 | |
| Former | Examination is in progress Status updated on 18.02.2020 | ||
| Former | Request for examination was made Status updated on 23.02.2018 | Most recent event Tooltip | 01.09.2023 | Withdrawal of application | published on 04.10.2023 [2023/40] | Applicant(s) | For all designated states Opko Diagnostics, LLC 4 Constitution Way Suite E Woburn, MA 01801 / US | [2018/13] | Inventor(s) | 01 /
Steinmiller, David 174 San Andreas Drive Menlo Park, CA California 94025 / US | 02 /
Linder, Vincent 246 Mitchell G Drive Tewksbury, MA Massachusetts 01876 / US | 03 /
Pettersson, Kim c/o Oy Arctic Partners Ab Yliopistonkatu 2 20100 Turku / FI | 04 /
Lovgren, Timo c/o Oy Arctic Partners Ab Yliopistonkatu 2 20100 Turku / FI | 05 /
Lilja, Hans 504 East 63rd Street Apt. 31S New York, NY New York 10065 / US | 06 /
Scardino, Peter T. 25 Sutton Place South 11G New York, NY New York 10022 / US | 07 /
Vickers, Andrew J. 374 Fifth Street Brooklyn, NY New York 11215 / US | [2018/13] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2018/13] | Application number, filing date | 17187203.9 | 27.03.2015 | [2018/13] | Priority number, date | US201461972099P | 28.03.2014 Original published format: US 201461972099 P | [2018/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3299977 | Date: | 28.03.2018 | Language: | EN | [2018/13] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 27.02.2018 | Classification | IPC: | G06F19/24, G16H50/20 | [2018/13] | CPC: |
G16H50/20 (EP,IL,US);
G01N33/57434 (IL,KR,US);
G16B20/00 (IL,KR,US);
G16B40/00 (IL,KR,US);
G16H50/30 (EP);
G01N2333/96455 (IL,KR,US);
Y02A90/10 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/13] | Validation states | MA | Not yet paid | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN IN ZUSAMMENHANG MIT DER DIAGNOSE VON PROSTATAKREBS | [2018/13] | English: | COMPOSITIONS AND METHODS RELATED TO DIAGNOSIS OF PROSTATE CANCER | [2018/13] | French: | COMPOSITIONS ET PROCÉDÉS CONCERNANT LE DIAGNOSTIC DU CANCER DE LA PROSTATE | [2018/13] | Examination procedure | 22.08.2017 | Examination requested [2018/13] | 22.08.2017 | Date on which the examining division has become responsible | 28.09.2018 | Amendment by applicant (claims and/or description) | 21.02.2020 | Despatch of a communication from the examining division (Time limit: M06) | 23.09.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 03.12.2020 | Reply to a communication from the examining division | 31.08.2023 | Application withdrawn by applicant [2023/40] | 12.09.2023 | Date of oral proceedings | Parent application(s) Tooltip | EP15768735.1 / EP3123381 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 03.12.2020 | Request for further processing filed | 03.12.2020 | Full payment received (date of receipt of payment) Request granted | 03.12.2020 | Decision despatched | Fees paid | Renewal fee | 22.08.2017 | Renewal fee patent year 03 | 27.03.2018 | Renewal fee patent year 04 | 27.03.2019 | Renewal fee patent year 05 | 27.03.2020 | Renewal fee patent year 06 | 29.03.2021 | Renewal fee patent year 07 | 28.03.2022 | Renewal fee patent year 08 | 27.03.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2013273643 (VICKERS ANDREW J [US], et al) [Y] 2,5-7 * abstract, [0005], [0008], [0073], [0099]-[0101], Fig. 2 *; | [IY]WO2013172779 (PHADIA AB [SE]) [I] 1,15-20 * abstract, pg. 4, pg. 7 l. 24, pg. 19 l. 7-30, pg. 34 l. 5-9 and 30, pg. 35 l.7-12, claims 26-30 * [Y] 2,5-7; | [Y] - OESTERLING J E ET AL, "Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration", UROLOGY, BELLE MEAD, NJ, US, vol. 42, no. 3, ISSN 0090-4295, (19930901), pages 276 - 282, (19930901), XP026409979 [Y] 2,5-7 * abstract * | [A] - A GUPTA ET AL, "A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands", BRITISH JOURNAL OF CANCER, GB, (20100801), vol. 103, no. 5, doi:10.1038/sj.bjc.6605815, ISSN 0007-0920, pages 708 - 714, XP055450564 [A] 1,2,5-7,15-20 * the whole document * DOI: http://dx.doi.org/10.1038/sj.bjc.6605815 | [A] - VICKERS A J ET AL, "A PANEL OF KALLIKREIN MARKERS CAN REDUCE UNNECESSARY BIOPSY FOR PROSTATE CANCER: DATA FROM THE EUROPEAN RANDOMIZED STUDY OF PROSTATE CANCER SCREENING (ERSPC) IN GOTEBORG, SWEDEN", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 179, no. 4, doi:10.1016/S0022-5347(08)62097-2, ISSN 0022-5347, (20080401), page 719, (20080401), XP025798780 [A] 1,2,5-7,15-20 * the whole document * DOI: http://dx.doi.org/10.1016/S0022-5347(08)62097-2 | by applicant | US2013273643 | - THOMPSON IM; ANKERST DP; CHI C; GOODMAN PJ; TANGEN CM; LUCIA MS; FENG Z; PARNES HL; COLTMAN CA JR, "Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial", Journal of the National Cancer Institute, (20060000), vol. 98, doi:doi:10.1093/jnci/djj131, pages 529 - 534, XP055100812 DOI: http://dx.doi.org/10.1093/jnci/djj131 | - VICKERS A.J. et al., "Net benefit and threshold probability were established using methods disclosed", Med Decis Making, (20060000), vol. 26, no. 6, pages 565 - 574 |